ULCERATIVE COLITIS CHRONIC MODERATE
Clinical trials for ULCERATIVE COLITIS CHRONIC MODERATE explained in plain language.
Never miss a new study
Get alerted when new ULCERATIVE COLITIS CHRONIC MODERATE trials appear
Sign up with your email to follow new studies for ULCERATIVE COLITIS CHRONIC MODERATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut bacteria tested as potential treatment for bowel disease
Disease control Recruiting nowThis early-stage study is testing the safety and effects of an oral probiotic called R-3750 in adults with mild to moderate ulcerative colitis. Researchers will monitor side effects and check if the probiotic reduces bowel inflammation and improves symptoms. The goal is to see if…
Matched conditions: ULCERATIVE COLITIS CHRONIC MODERATE
Phase: PHASE1 • Sponsor: Rise Therapeutics LLC • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for Tough-to-Treat colitis flares
Disease control Recruiting nowThis study is testing a new oral drug called BRS201 for adults experiencing a severe flare-up of ulcerative colitis who haven't gotten better with steroid treatment. Over 12 weeks, participants will take the study drug for 4 weeks and have several clinic visits for check-ups and …
Matched conditions: ULCERATIVE COLITIS CHRONIC MODERATE
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC